Table 4.
Reasons for No Risk Stratification.
| No (Unspecified) | No Established Protocols | Always Anticoagulate | Comorbidity Deponent | Uses Mechanical Methods | Defer to Other Specialty | Bleeding Risk | Total | |
|---|---|---|---|---|---|---|---|---|
| All continents | 31 | 11 | 18 | 12 | 2 | 3 | 1 | 78 |
| Africa | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 3 |
| Asia | 8 | 3 | 1 | 3 | 2 | 0 | 0 | 17 |
| Australia | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Europe | 6 | 3 | 8 | 5 | 0 | 1 | 0 | 23 |
| Middle East | 2 | 0 | 0 | 2 | 0 | 1 | 0 | 5 |
| North America | 3 | 2 | 3 | 1 | 0 | 0 | 0 | 9 |
| South America | 11 | 3 | 4 | 0 | 0 | 1 | 1 | 20 |
| P valuea | .260 | .949 | .094 | .102 | .276 | .456 | .705 | — |
a Calculation of P values was performed using Fisher exact test.